Experimental Vaccine 1
CXSL2200156-Ⅰ
Phase 1 mab completed
Quick answer
Experimental Vaccine 1 for COVID-19 Pneumonia is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- COVID-19 Pneumonia
- Phase
- Phase 1
- Modality
- mab
- Status
- completed